Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VESANOID
- Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL.
- Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer
- Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
- All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
- A Study of TAS1440 With ATRA in Subjects With r/r AML
- Phase IIb Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer
- ATRA Trial - ACTIVITY OF ATRA IN COMBINATION WITH ANASTROZOLE IN PRE-OPERATIVE PHASE OF OPERABLE HR-POSITIVE/HER2-NEGATIVE EARLY BREAST CANCER eBC ATRA TRIAL
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
- Stromal TARgeting for PAncreatic Cancer (STAR_PAC)
- Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
- IMG-7289, With and Without ATRA, in Patients With Advanced Myeloid Malignancies
- Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
- Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
- Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible
- Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Phase II 5-Azacytidine Plus VPA Plus ATRA
- Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy
- To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid
- 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS
- Phase II 5-Azacytidine Plus VPA Plus ATRA
- Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy
- Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Clinical trials list
click for details